4//SEC Filing
Branning Todd P. 4
Accession 0001104659-22-114954
CIK 0001173281other
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 5:00 PM ET
Size
5.9 KB
Accession
0001104659-22-114954
Insider Transaction Report
Form 4
Branning Todd P.
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2022-11-03+200,000→ 200,000 totalExercise: $0.28Exp: 2032-11-03→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]50% of the total shares shall vest on March 1, 2023, and the remaining shares shall vest on November 1, 2023, provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive. Shares are subject to accelerated vesting in the event of a change of control of the Issuer, provided that employment has not terminated prior to such vesting date, inclusive.
Documents
Issuer
NeuBase Therapeutics, Inc.
CIK 0001173281
Entity typeother
Related Parties
1- filerCIK 0001765274
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 8:00 PM ET
- Accepted
- Nov 4, 5:00 PM ET
- Size
- 5.9 KB